|
|
||||||||
Journal of Lipid Research, Vol 21, 1090-1096, Copyright © 1980 by Lipid Research, Inc.
Y Suzuki and R Tabata
Effects of 4-aminopyrazolo(3,4d)pyrimidine on pulmonary surface-active
material and its surface activity were investigated in the rat. A rapid
decrease in serum cholesterol was observed in rats treated with this drug
and these effects continued during the entire period of treatment.
Phosphatidylglycerol content in surface-active material and in the residual
lung decreased significantly during three days of treatment and
phosphtidylcholine content in surface-active material also decreased on the
third day of the treatment. There were no changes in the contents of other
phospholipids and cholesterol. The surface-active material from treated
rats showed a larger surface compressibility, an elevated minimum surface
tension, and a low stability index, as compared to control rats. These
results show that alteration of lipid constituents significantly affects
the surface properties of pulmonary surface-active material and that
4-aminopyrazolopyrimidine is a drug which can be effectively utilized to
investigate lipid metabolism of the lung.
ARTICLES
Selective reduction of phosphatidylglycerol and phosphatidylcholine in pulmonary surfactant by 4-aminopyrazolo(3,4d)pyrimidine in the rat
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
S. R. Bates, J.-Q. Tao, H. L. Collins, O. L. Francone, and G. H. Rothblat Pulmonary abnormalities due to ABCA1 deficiency in mice Am J Physiol Lung Cell Mol Physiol, December 1, 2005; 289(6): L980 - L989. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |